|
[news 2005
- 2006]
PARTEQ,
University of Toronto announce strategic alliance to
commercialize research discoveries
For immediate release
Monday, Nov. 20, 2006
KINGSTON, ON -- Queen’s University’s PARTEQ
Innovations and University of Toronto’s Innovations
at U of T (IUT) are pleased to announce a strategic
alliance directed at commercializing discoveries generated
by university research.
The new alliance, which will initially involve the respective
technology transfer offices of Queen’s University
and University of Toronto, will work jointly towards
a shared goal of enhancing Ontario’s overall research
commercialization capacity.
The focus will be on finding, funding and developing
research discoveries with commercial potential, with
the partners providing complementary expertise and resources.
Leading the alliance are Mr. John Molloy, President
and CEO of PARTEQ and Dr. Tim McTiernan, Assistant Vice-President,
Research, and Executive Director of Innovations at University
of Toronto. They made the announcement at the annual
meeting of the Alliance for the Commercialization of
Canadian Technology (ACCT), the national organization
of technology transfer professionals at Canada’s
universities and research institutions.
“Essentially, this alliance is recognition that
when it comes to commercializing research, none of us
can do it all,” says Mr. Molloy. “It’s
acknowledgment that by calling on one another’s
strengths as opportunities and needs arise, we all become
more effective.”
“This is a tremendous opportunity to connect key
commercialization centres and is a natural extension
of IUT’s collaborations in Toronto with MaRS and
BioDiscovery Toronto,” says Dr. McTiernan. “By
agreeing to pool our resources, expertise, and commercialization
opportunities, our alliance can make the most of the
promising discoveries arising from leading research
at our respective universities. This agreement marks
the next stage in the evolution of Ontario’s innovation
and commercialization pipeline.”
While each of the institutions brings distinctive strengths
to the growing field of research commercialization,
leveraging one another’s resources and technology
specializations will greatly enhance the volume and
quality of the province’s overall innovation pipeline,
the partners say.
They describe their approach as an extension of the
Ontario Commercialization Network, recently established
by the Ontario Ministry of Research and Innovation.
“This model puts into tangible form the ministry’s
desire for greater collaboration and capacity-building
among the province’s many players in the innovation
commercialization field,” Dr. McTiernan says.
“It’s about breaking down the barriers to
collaboration and building a seamless network of players
who can help to bring forward-looking technologies to
market.”
“This is an important step in enhancing the potential
of publicly funded research,” says Mr. Molloy.
“This kind of sharing and collaboration is essential,
because ultimately our goals are the same: to ensure
that the innovative technologies generated by university
research reach the market, benefiting our society and
our economy.”
Contact:
Dr. Tim McTiernan
Executive Director
Innovations
at U of T
416. 946. 7342
Mr. John Molloy,
President & CEO
PARTEQ Innovations
613. 533. 2322
About Innovations at U of T:
Innovations at U of T (IUT) is the research commercialization
arm of the University of Toronto. As a department of
the Office of the Vice-President, Research & Associate
Provost, IUT works with U of T faculty and our healthcare
partners in bringing their research to the marketplace.
IUT (formerly known as the University of Toronto Innovations
Foundation) has evaluated thousands of ideas in the
Physical Sciences, Life Sciences and Information Technology
and has taken the best to many of the biggest names
in the business world in the fields of drug development,
biodiesel fuel, agriculture, finance, mining, and many
others.
http://innovations.utoronto.ca
About PARTEQ Innovations:
PARTEQ Innovations is the not-for-profit technology
transfer arm of Queen’s University. PARTEQ works
with Queen’s researchers and the business and
venture capital communities to bring early stage technologies
to market. Since 1987 PARTEQ has been instrumental in
the establishment of nearly 40 companies developing
a variety of products, from potential drugs for Alzheimer’s,
cancer and heart disease to automated bacteria detection
for water systems, solar-powered appliances, and advanced
materials used in the plastics, automotive, aerospace
and household appliance industries.
www.parteqinnovations.com
|